Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2013
04/03/2013CN103006683A Pharmaceutical composition of 12 complex vitamins for injection and preparation method thereof
04/03/2013CN103006663A Rosuvastatin calcium pharmaceutical composition
04/03/2013CN103006655A Application of chloroform extract of inonotus obliquus liquid fermentation product in preparation of antidiabetic drugs
04/03/2013CN103006652A Pharmaceutical composition capable of reducing blood pressure and blood fat simultaneously and preparation method of pharmaceutical composition
04/03/2013CN103006643A Compound injection containing 18 amino acids and preparation method thereof
04/03/2013CN103006641A Application of alpha-zinc sulfate in preparing medicament for treating diabetes mellitus complication
04/03/2013CN103006605A Bendazac lysine sustained release preparation as well as preparation method and application of preparation
04/03/2013CN103006602A Quickly-dissolved atorvastatin calcium tablet and preparation method thereof
04/03/2013CN103006601A Orlistat tablet and preparation method thereof
04/03/2013CN103006597A Voglibose tablet and preparation method thereof
04/03/2013CN103006594A Glimepiride composite and preparation method thereof
04/03/2013CN103005960A Medical pillow
04/03/2013CN103005462A Composition for preventing and improving metabolic syndrome
04/03/2013CN103005096A Mixed tea and mixed tea, as well as preparation method thereof
04/03/2013CN103005057A Health care tea capable of reducing blood sugar and preparation method thereof
04/03/2013CN102641311B Kiwi fruit seed oil liposome oral liquid and preparation method thereof
04/03/2013CN102488251B Sea cucumber gelatin, preparation method thereof, medicine or health product containing sea cucumber gelatin, and application of sea cucumber gelatin
04/03/2013CN102428832B Fungal pharmaceutical mycoplasm with blood sugar lowering efficacy and preparation method thereof
04/03/2013CN102370612B Chitosan-monomethoxy polyethylene glycol gel delivery system and preparation method thereof
04/03/2013CN102366497B Medicinal compound preparation for treating diabetes and preparation method of medicinal compound preparation
04/03/2013CN102366495B Self-heated traditional Chinese medicine (TCM) emplastrum for lowering lipid and losing weight
04/03/2013CN102335255B Chinese medicine for treating hyperlipidemia and fatty liver and preparation method thereof
04/03/2013CN102335249B Oral capsule for treating II-type diabetes
04/03/2013CN102302549B Drug composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof
04/03/2013CN102302533B Application of brassica rapa organic acid to preparation of medicaments for reducing blood sugar
04/03/2013CN102274182B Multivesicular liposome containing exenatide, preparation method and application thereof
04/03/2013CN102260268B Benzylthio acetamido acetylpyrazine triazole derivative as well as preparation thereof and application thereof
04/03/2013CN102258555B Application of turnip total saponins to preparing hypoglycemic medicament
04/03/2013CN102258543B Method for processing lucid ganoderma
04/03/2013CN102250778B Lachnum sp., extracellular polysaccharide thereof and application of extracellular polysaccharide in lipid-lowering liver-favoring medicaments
04/03/2013CN102234303B Novel ecdysterone synthetic derivative and preparation method and application thereof
04/03/2013CN102188425B Bilayer tablet containing niacin and simvastatin, and preparation method thereof
04/03/2013CN102161619B Ferulic acid Jiangtang compound salt as well as preparation method and application thereof
04/03/2013CN102079726B Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound
04/03/2013CN102060904B Celosia argentea L. saponin compounds and application thereof
04/03/2013CN102047997B Wuyi Mountain rock tea extract, and preparation method and application thereof
04/03/2013CN101897689B Application of N-acetyl phenylalanine derivatives to inhibition of urease activity
04/03/2013CN101857594B Tetrahydropyridoindole compounds, and preparation method and application thereof
04/03/2013CN101716182B Combined medicine containing metformin hydrochloride and vitamin B12
04/03/2013CN101711162B Processed product of fenugreek seed, and method for production thereof
04/03/2013CN101631555B Prophylactic agent for autoimmune disease
04/03/2013CN101538230B Beta-amino ketones compound with anti-diabetic activity
04/03/2013CN101502323B Elemental diet suitable for severe patient and patient with metabolic intestinal dysfunction as well as preparation method thereof
04/03/2013CN101445457B Isosteviol derivant and application thereof
04/03/2013CN101380070B Apples honey sauce with weight reduction function
04/03/2013CN101297692B Extraction of glycosides from Vaccinium dunalianum Wight var. dunalianum and use thereof in health products
04/03/2013CN101272795B Agent for amelioration of insulin resistance
04/02/2013US8410253 Scavenger receptor
04/02/2013US8410174 Method for treating arthritis
04/02/2013US8410132 Modulators of cystic fibrosis transmembrane conductance regulator
04/02/2013US8410119 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/02/2013US8410057 Method of inducing T cell apoptosis by administering Altered Peptide Ligand
04/02/2013US8410053 Methods for treating autoimmune disorders, and reagents related thereto
04/02/2013US8410047 Counteracting drug-induced obesity using GLP-1 agonists
04/02/2013US8409617 Vitamin powder composition and method of making
04/02/2013US8409561 Methods and compositions for treatment of ion imbalances
04/02/2013US8409548 Administration of growth factors for the treatment of CNS disorders
04/02/2013CA2728541C Crystalline forms of thiazolidinedione compound and its manufacturing method
04/02/2013CA2726754C N-substituted-2-oxodihydropyridine derivatives
04/02/2013CA2715143C Novel phenylpyrrole derivative
04/02/2013CA2585642C Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof
04/02/2013CA2550843C Novel phenylalanine derivatives
04/02/2013CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3
04/02/2013CA2455756C Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
04/02/2013CA2420652C Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
04/02/2013CA2396212C Recombinant antibodies to human interleukin-1 beta
03/2013
03/28/2013WO2013043960A1 Compounds useful as inhibitors of choline kinase
03/28/2013WO2013043925A1 Sodium channel blockers reduce glucagon secretion
03/28/2013WO2013043817A1 Antisense modulation of gcgr expression
03/28/2013WO2013043719A1 Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance
03/28/2013WO2013043192A1 Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
03/28/2013WO2013043143A1 Method for reducing excess weight
03/28/2013WO2013043085A1 Pharmaceutical substance (variants) and compositions based thereon which exhibit modulatory activity with a commensurate effect
03/28/2013WO2013042121A1 Beta-lactam compounds for treating diabetes
03/28/2013WO2013041519A1 Ror gamma modulators
03/28/2013WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
03/28/2013WO2013040784A1 Lyophilizing insulin liposome powder, oral insulin complex preparation, preparation method therefor, and use thereof
03/28/2013WO2013040712A1 Composition comprising ku ding cha and ginseng for managing blood glucose levels
03/28/2013WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
03/28/2013WO2013006692A3 Methods of treatment using a pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1)
03/28/2013WO2012173410A3 Novel c-aryl ansa sglt2 inhibitors
03/28/2013WO2012165916A3 Non-peptidyl polymer-insulin multimer and method for producing the same
03/28/2013WO2012165915A3 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
03/28/2013WO2012165914A3 Novel diphenylmethane derivatives as sglt2 inhibitors
03/28/2013WO2012165888A9 Composition for treating obesity and diabetes and for increasing muscle mass and improving capacity for exercise, comprising extracts of piper retrofractum vahl. fruits as active ingredients
03/28/2013WO2012158018A3 Compositions comprising extracts or materials derived from palm oil vegetation liguor for inhibition of vision loss due to angiogenesis and method of preparation thereof
03/28/2013WO2010130779A3 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases
03/28/2013US20130079411 Method for preventing or treating a disease, disorder or condition induced by retina ischemia
03/28/2013US20130079391 Lipase inhibiting composition
03/28/2013US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands
03/28/2013US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands
03/28/2013US20130079354 Pyridyl derivatives and their use as therapeutic agents
03/28/2013US20130079321 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/28/2013US20130079317 Methods for treatment of diseases
03/28/2013US20130079278 Novel Glucagon Analogues
03/28/2013US20130078314 Transdermal method of delivering nutrients into human body
03/28/2013US20130078258 Cachexia Treatment
03/28/2013US20130078237 Cd27l antigen binding proteins
03/28/2013US20130078228 Vitamin-containing nutrition infusion for administration through peripheral vein
03/28/2013CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof